Goldman Sachs analyst Bonnie Herzog assumed coverage of Clorox with a Sell rating and $140 price target. While the company has made significant progress on distribution recovery, there are still pockets where recovery in distribution and service levels is taking longer, the analyst tells investor sin a research note. The firm is cautious on medium- to longer-term trends for Clorox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CLX:
- Clorox Declares Regular Quarterly Dividend of $1.20 Per Share
- Charter downgraded, Cigna upgraded: Wall Street’s top analyst calls
- DA Davidson downgrades Clorox with upgrade thesis played out
- Clorox downgraded to Neutral from Buy at DA Davidson
- Early notable gainers among liquid option names on February 2nd
